The diabetic sarcopenia nutrition market is expected to grow significantly, with a projected increase from USD 263.4 million in 2026 to USD 658.7 million by 2036, reflecting a compound annual growth rate (CAGR) of 9.6% between 2026 and 2036. This growth is attributed to the rising number of older adults with diabetes who experience muscle loss and inadequate nutrition.
Read More
The market's valuation is predicted to increase from USD 240.3 million in 2025 to USD 263.4 million in 2026, driven by the growing clinical demand for specific nutrition aimed at preserving muscle mass among older adults. As reported by the International Diabetes Federation in April 2025, there are currently 589 million adults living with diabetes globally, emphasizing the need for targeted nutrition solutions.
Demand for diabetic sarcopenia nutrition is not uniform across countries; Japan is forecasted to grow at a CAGR of 10.2%, followed by South Korea at 9.9%. The USA is expected to grow at 9.2%, while the UK and Germany are projected at 8.9% and 8.3% respectively. Factors influencing growth include healthcare access, preferences for specialized nutrition, and the need to address muscle loss in diabetic patients.
Key trends in this market indicate a growing preference for low-glycemic-index (GI) high-protein nutritional products, which are expected to constitute 41.6% of market demand in 2026. Ready-to-drink (RTD) products are anticipated to dominate at 46.3% market share due to their convenience for older adults.
In terms of demographics, adults aged 60-69 years are predicted to represent the largest consumer group at 48.9% in 2026, as they typically manage their diabetes independently and are likely to incorporate specialized nutrition into their routines.
Homecare is projected to be the primary end-user segment, comprising 47.2% of market demand in 2026, as nutrition usage often continues at home following clinical initiation. Hospital pharmacies are expected to account for 39.4% of sales due to clinician-led recommendations.
The market features several notable companies, including Abbott, Nestlé Health Science, and Danone Nutricia, which focus on developing products that address both diabetes management and muscle preservation. Recent developments indicate a trend towards compact and effective nutritional formulations suitable for older adults with varying dietary needs and preferences.